BCL2 and prostate adenocarcinoma: The present analysis was done to test the possible prognostic value of abnormal expression of the bcl-2 protein in prostatic adenocarcinoma associated with the Gleason score, which was divided into two extreme groups: a low score (2-4) and a high score (8-10).